You are on page 1of 2

Nifty Pharma

December 31, 2015


Nifty Pharma Index captures the performance of the pharmaceutical sector. The Index comprises of 10 companies listed on National
Stock Exchange of India (NSE).
Nifty Pharma Index is computed using free float market capitalization method, wherein the level of the index reflects the total free
float market value of all the stocks in the index relative to particular base market capitalization value. Nifty Pharma Index can be used
for a variety of purposes such as benchmarking fund portfolios, launching of index funds, ETFs and structured products.
Index Variants: Nifty Pharma Total Returns Index.

Eligibility Criteria for Selection of


Constituent Stocks
i. Companies must rank within the top 500
companies by average free-float market
capitalization and aggregate turnover for the
last six months.
ii. C o m p a n i e s s h o u l d f o r m a p a r t o f
pharmaceutical sector.

Index
Methodology

iv. The company should have reported a


positive net worth.

vi. The company should have a listing history


of 6 months. A company, which comes out
with an IPO will be eligible for inclusion in
the index, if it fulfills the normal eligibility
criteria for the index for a 3 month period
instead of a 6 month period.
vii. Final selection of 10 companies shall be
done based on the free-float market
capitalization of the companies.

Thomson Reuters:
.CNXPHARM
Contact Us:
Email: iisl@nse.co.in
Tel: +91 22 26598386
Fax: +91 22 26598120

Index is re-balanced on semiannual


basis. The cut-off date is January 31 and
July 31 of each year, i.e. For semiannual review of indices, average data
for six months ending the cut-off date is
considered. Four weeks prior notice is
given to market from the date of change.

iii. The company's trading frequency should be


at least 90% in the last six months.

v. The company should have an investable


weight factor (IWF) of at least 10%.

Bloomberg:
CNXPHRM Index

Index Re-Balancing:

Index Govenance:
A professional team at IISL manages
Nifty Pharma Index. There is a three-tier
governance structure comprising the
Board of Directors of IISL, the Index
Policy Committee, and the Index
Maintenance Sub-Committee.

Nifty Pharma
December 31, 2015

Portfolio Characteristics
Methodology
No. of Constituents
Launch Date
Base Date
Base Value
Calculation Frequency
Index Rebalancing

Statistics
Free Float Market Capitalization
10
July 01, 2005
January 01, 2001
1000
Real-time Daily
Semi-Annually

1 Year Performance Comparison of Sector Indices

Since
1 Year 5 Years Inception
9.26
18.65
17.99

QTD YTD
Returns (%)# -8.96

9.26

0.85
0.63

Since
Inception
20.08
16.45
0.53
0.55
0.54
0.66

P/B
6.43

Dividend Yield
0.51

1 Year
Std. Deviation *
Beta (Nifty 50)
Correlation (Nifty 50)

5 Years

21.72

Fundamentals
P/E
60.61

Top 10 constituents by weightage


Companys Name

Weight
(%)

Sun Pharmaceutical Industries Ltd.

31.82

Lupin Ltd.

15.74

Dr. Reddy's Laboratories Ltd.

14.06

Cipla Ltd.

11.74

Aurobindo Pharma Ltd.

8.39

Divi's Laboratories Ltd.

5.23

Glenmark Pharmaceuticals Ltd.

4.60

Cadila Healthcare Ltd.

3.01

Piramal Enterprises Ltd.

2.92

Glaxosmithkline Pharmaceuticals Ltd.

2.50

# QTD,YTD and 1 year returns are absolute returns.Returns for greater than one year are CAGR returns.
* Average daily standard deviation annualised
Disclaimer: All information contained herewith is provided for reference purpose only. IISL ensures accuracy and reliability of the above information to the best of its endeavors. However, IISL
makes no warranty or representation as to the accuracy, completeness or reliability of any of the information contained herein and disclaim any and all liability whatsoever to any person for any
damage or loss of any nature arising from or as a result of reliance on any of the information provided herein. The information contained in this document is not intended to provide any
professional advice.